Rodob Drug Research Inc is categorized under Research and Development Laboratories in Gainesville, FL and active since 2009.
Rodob Drug Research Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Nicholas S Bodor at the company’s single location by writing to 3929 Sw 69th Avenue, Gainesville, Florida FL 32608 or by phoning (352) 377-2988. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Rodob Drug Research Inc |
Contact Person: | Nicholas S Bodor |
Address: | 3929 Sw 69th Avenue, Gainesville, Florida 32608 |
Phone Number: | (352) 377-2988 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2009 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Research and Development Laboratories |
SIC Code: | 8731 |
NAICS Code: | 541712 |
Share This Business: |
Rodob Drug Research Inc was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Nicholas S Bodor for inquiries that concern Rodob Drug Research Inc by calling the company number (352) 377-2988, as your correspondence is most welcome. Additionally, the physical location of the single location of Rodob Drug Research Inc can be found at the coordinates 29.589883,-82.379278 as well as the street address 3929 Sw 69th Avenue in Gainesville, Florida 32608.
For its online presence, you may visit Rodob Drug Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.